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Abstract
Background: The environmental factors that determine the elevated levels of polyclonal IgE observed in populations
living in the Tropics are poorly understood but may include geohelminth infections. We investigated the association
between geohelminth infections and total IgE levels in school children in rural tropical Ecuador, and assessed the effect
on IgE of repeated anthelmintic treatments over a period of 12 months. The study was nested within a cluster-
randomized study that randomized 68 schools to receive either 400 mg of albendazole every 2 months over a year or
no treatment. We studied random samples of children completing follow-up and representing four groups stratified by
the presence of geohelminth infection at baseline and treatment allocation. We measured levels of total IgE and anti-A.
lumbricoides IgG (used as a measure of past and current geohelminth infectious exposure) in blood samples collected at
the start of the study and after 12 months.
Results: We observed elevated levels of total IgE (compared to standard reference values) at the start of the study in
this population of school children (geometric mean, 1,004 IU/mL, range 12 to 22,608 IU/mL)) and baseline IgE levels were
strongly associated with parameters of geohelminth infection but not with age, nutritional and socioeconomic status.
After 12 months, levels of IgE fell significantly in the treatment (by 35.1%) and no treatment (by 10.4%) groups,
respectively, but the fall was significantly greater in the treatment group. Falls in IgE were independently associated with
albendazole treatment, having a baseline geohelminth infection and with high baseline levels of anti-A. lumbricoides IgG.
Increases in IgE at 12 months were associated with the presence of geohelminth infections and increasing levels of anti-
A. lumbricoides IgG at 12 months independent of treatment allocation.
Conclusion: The data provide evidence that geohelminth infections are an important determinant of total IgE in school
children in the rural Tropics and that periodic anthelmintic treatments over 12 months are associated with reductions
in IgE. The failure of anthelmintic treatment to reduce IgE levels to that considered normal in industrialized countries
may be attributed to continued exposure of children to geohelminths or to the effects of infections in early life in
programming a long-lasting Th2-biassed immunity.
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Levels of polyclonal IgE in the peripheral blood of poor
rural [1] and urban populations [2-4] living in the tropics
are highly elevated compared to levels observed in wealth-
ier urban populations in the same countries [5] or in pop-
ulations living in industrialized countries [6]. Total IgE
levels in industrialized countries are affected by age [7]
and genetic factors [8] and are associated with ethnicity
and socioeconomic status [9]. The causes of the high cir-
culating levels of IgE in poor tropical populations are
poorly understood but have been attributed again to
genetic factors [10,11] and also to infections with geo-
helminth (intestinal helminth) parasites [12].
Geohelminth parasites are the most prevalent of all
helminth infections and are estimated to infect approxi-
mately 2 billion humans worldwide [13]. Important geo-
helminth parasites include Ascaris lumbricoides, Trichiuris
trichiura, hookworm, and Strongyloides stercoralis. Infec-
tions with these parasites induce strong immunological
responses in infected humans that are associated with the
production of type 2 cytokines including IL-4, IL-5, and
IL-13 [14,15]. The high levels of polyclonal IgE observed
in populations living in areas that are endemic for geo-
helminth parasites may be caused by non-specific stimu-
lation of polyclonal IgE by geohelminths through an IL-4-
dependent mechanism [16]. A possible causal association
between geohelminth infections and levels of total IgE
may be suggested by the observation that IgE levels
decline after effective anthelmintic treatment [16-18].
The objective of the present study was to investigate the
association between total IgE and geohelminth infections
and other risk factors in school children living in an area
of the rural tropics that is highly endemic for geohelminth
parasites, and to examine the effect of repeated
anthelmintic treatments for a period of a year on levels of
total IgE.
Methods
Subjects and sampling
School children attending schools in rural areas of Pichin-
cha Province in Ecuador were sampled within a cluster-
randomized study that examined the effect of albendazole
treatment on the prevalence of allergy. The study design is
described in detail elsewhere [19]. Briefly, mestizo chil-
dren attending the second to seventh year of primary edu-
cation in 68 rural schools were recruited. Schools were
randomized to receive either albendazole (single doses of
400 mg provided every 2 months for a period of 12
months [total of 7 treatments] or no treatment. Albenda-
zole treatments were directly observed and a placebo was
not used in the no-treatment group. A total of 1,632 chil-
dren (68.8% of 2,373 children that were recruited at the
start of the study – follow-up rates were similar in treat-
ment (67.4%) and no-treatment (70.1%) groups) – com-
pleted follow-up at 12 months in the 68 schools but 23 of
these children with no baseline stool results were
excluded from the analysis. Four samples of each of 100
individuals were selected randomly from the remaining
1,609 children to represent the four possible combina-
tions of treatment and baseline infection as follows: 1)
infection/no treatment (sampling fraction, 100/622) –
children in the no treatment group that were infected at
the beginning of the study with geohelminths; 2) no
infection/no treatment (100/214) – children in the no
treatment group that were not infected with geohelminths
at the beginning of the study; 3) infection/treatment
(100/543) – children in the treatment group that were
infected with geohelminths at the beginning of the study;
and 4) no infection/treatment (100/230) – children in the
treatment group that were not infected with geohelminths
at the beginning of the study. The study protocol was
approved by the Ethics Committees of St George' Univer-
sity of London, London, UK, and the Hospital Pedro Vice-
nte Maldonado, Pichincha Province, Ecuador. Informed
written consent to participate in the study was obtained
from a parent or guardian of all children.
Sample collection and analysis
Stool samples were collected from children at the begin-
ning of the study (i.e. before receiving the 1st dose of
albendazole) and at 12 months (i.e. before receiving the
7th dose of albendazole). Blood samples (3 mL) were
drawn from the antecubital fossa into Vacutainers (Becton
Dickinson) containing sodium heparin as anticoagulant
at the beginning of the study and 7 days after receiving the
7th dose of albendazole. The blood was centrifuged and
the plasma aliquotted and stored at -20C until use. Total
IgE was measured in IU/mL as described previously [1].
Levels of A. lumbricoides – specific total IgG antibodies
were measured by an antibody-capture ELISA as described
[14]. Briefly, plates were coated with a PBS-soluble extract
of A. lumbricoides adult female worms (obtained by expul-
sion after anthelmintic treatment) at 2.5 μg/mL in carbon-
ate buffer. After incubation with plasma samples diluted
at 1/100, the plates were incubated with alkaline phos-
phatase conjugated anti-human IgG (Jackson ImmunoRe-
search), developed with p-nitrophenyl phosphate
(Sigma) in sodium carbonate buffer, and read on a micro-
titer plate reader. Unknown values were interpolated from
a standard curve derived from pools of positive serum
samples, and antibody levels were expressed as arbitrary
units. The cut-off for a positive serologic test for Ascaris
lumbricoides-specific IgG was defined as mean plus 3
standard deviations of antibody levels obtained from 8
individuals resident in the town of Quinindé in Esmeral-
das Province with no previous history of geohelminth
infection. Stool samples were examined using the modi-Page 2 of 11
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methods as described [20].
Statistical analysis
The random samples that comprised the four study
groups were generated using computer software (Stata 7,
Stata Corporation, College Station, Texas, USA). Children
were analysed according to their original treatment alloca-
tion. The primary outcomes were baseline levels of IgE
and fold change in total IgE expressed as a percentage
(100*posttreatment IgE/pretreatment IgE). Secondary
outcomes were baseline levels of anti-A. lumbricoides IgG
and changes in anti-A. lumbricoides IgG expressed as a per-
centage also. All analyses used logarithmically trans-
formed data for the dependent continuous variables of
baseline IgE and changes in IgE. The results of trans-
formed data for IgE parameters were back-transformed to
compare explanatory variables in terms of ratios (fold dif-
ferences) of geometric means. Changes in IgE levels com-
pared to baseline were assessed using the one-sample t
test. Inter-group differences for IgE outcomes were
assessed using one-way analysis of variance (for 4 group
comparisons) and Student's t test (for 2 group compari-
sons). Multivariable analyses for IgE and anti-A. lumbri-
coides IgG outcomes used linear regression and controlled
for the a priori confounding factors, age, sex, body mass
index, socioeconomic level and household crowding.
Clustering by school was adjusted for using the sandwich
estimator ('robust cluster' in STATA). Four models were
used to explore the associations between geohelminth
infections and the primary IgE outcomes. The models
were chosen to investigate the independent effects on
these outcomes of different parameters of geohelminth
infections including the presence of any infection and
exposure to any infection, the presence of infections with
different geohelminth parasites, and infection intensities
with A. lumbricoides and T. trichiura (the predominant geo-
helminth parasites in the study area). The models were:
Model 1 – association with any geohelminth infection;
Model 2 – associations with individual geohelminth par-
asite infections; Model 3 – associations with infection
intensities with A. lumbricoides and T. trichiura; and Model
4 – associations with geohelminth prevalence, and expo-
sure to geohelminth parasites. Exposure to geohelminth
infection was measured by anti-A. lumbricoides IgG anti-
bodies – because there is extensive immunologic cross-
reactivity between antigen preparations from different
geohelminth parasites [21], the presence of IgG antibod-
ies to A. lumbricoides is likely to indicate past and or
present exposures to geohelminth infections including A.
lumbricoides and antibody levels are likely to be associated
with the intensities of current and recent infections. Linear
regression models for changes in IgE included also param-
eters for geohelminth infection at 12 months. The second-
ary outcomes, baseline levels and changes in anti-A.
lumbricoides IgG, were logarithmically transformed and
analysed using Model 3 only. Bonferroni corrections were
used to conservatively reduce the probability of Type I
errors in those multivariable analyses involving multiple
geohelminth-associated variables – the original signifi-
cance level of 5% was divided by the number of such var-
iables in each analysis to obtain an adjusted significance
level for them. Therefore, the multiples used for Models 1,
2, 3, and 4 for total IgE and changes in total IgE were: 1, 4,
6, and 3 and 2, 8, 12, and 6, respectively, Bonferroni cor-
rections for multivariable analyses of baseline and
changes in anti-A. lumbricoides IgG were as for Model 3.
Socioeconomic status was calculated as a score divided
into quartiles and based on paternal and maternal educa-
tional level (categorized as illiterate [lowest] to completed
higher education [highest]) and occupation (i.e. catego-
rized as day-labourer [lowest] to professional [highest]),
and the number of material goods in the household
(radio, television, refrigerator, and sound system). Each
variable was assigned a score and the range of scores was
divided into quartiles numbered 1 to 4 representing the
richest to poorest quartiles, respectively. Each individual
was assigned a final quartile socioeconomic level score of
1 to 4. Geohelminth infection intensities were stratified
into three groups (negative, and two positive groups
[above and below the median]), and anti-A. lumbricoides
IgG, when used as an independent variable, into tertiles.
Tests for trend were included in the regression models by
allocating ordinal scores (0, 1 and 2) to the categories in
ascending order, and retaining the other model covariates.
Analyses were done with Stata version 8.0.
Results
General characteristics of study groups
The baseline characteristics of the study groups are shown
in Table 1. The mean age, sex distribution, and mean lev-
els of crowding (number of persons per sleeping room)
were similar between the 4 groups. Socioeconomic level
was significantly different between the 4 study groups (P
< 0.0001) and tended to be lower (i.e. higher score) in
infected children in both treatment groups compared to
the respective non-infected groups. A. lumbricoides and T.
trichiura infections were the main geohelminth infections
present in this population, and the prevalence of all 4 geo-
helminths present in this sample were similar between the
2 infection groups (infection/no treatment and infection/
treatment). A total of 185 of the 200 (93%) individuals in
the two treatment groups (infection/treatment and no
infection/treatment) received all 7 albendazole treat-
ments, and only 4 individuals received 3 or fewer treat-
ments. Treatment was incomplete in the treatment group
as a consequence of failure of a few children to attend the
school on treatment days or moving house from a treat-
ment to a no treatment school over the course of the study
(3 children). Five individuals in the no treatment groupsPage 3 of 11
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as a consequence of moving to a treatment school during
the 12-month observation period.
Changes in prevalence of geohelminth infections
Changes in the prevalence of geohelminth infections are
shown in Figure 1. The prevalence of infection with any
geohelminth parasite declined significantly from 100% to
67% in the infection/no treatment group (P < 0.001) and
group from 100% to 24% (P < 0.001) in the infection/
treatment group. The treatment effect on geohelminth
prevalence at 12 months was statistically significant (OR
0.39, 95% CI 0.29–0.54, P < 0.001), indicating a 61% rel-
ative reduction in geohelminth prevalence in the treat-
ment compared to the no treatment group. Anthelmintic
treatment was more effective for A. lumbricoides than T.
trichiura. Forty-two percent of individuals in the no infec-
tion/no treatment group acquired geohelminth infections
over the 12-month period compared to 9% of individuals
in the no infection/treatment group. No infections with
hookworm and S. stercoralis were observed in either of the
two treatment groups at 12 months. The decline in geo-
helminth prevalence in the no treatment group may have
been caused by treatment contamination. Anthelmintic
treatment is widely available without prescription in phar-
macies and dispensaries throughout Ecuador, and moth-
ers frequently administer anti-parasite drugs to their
children without medical consultation. Five individuals
in the non-treated communities actually moved from
treated to non-treated communities over the 12 month
study period and had documented treatments with alben-
dazole.
Factors associated with total IgE at baseline
Geometric mean levels of IgE in the study population
were 1,004 IU/mL (range 12–22,608 IU/mL) and were
similar between the infection (infection/no treatment,
1,315 IU/mL vs. infection/treatment, 1,566 IU/mL, P =
0.34) and the no infection groups (no infection/no treat-
ment, 825 IU/mL vs. no infection/treatment, 599 IU/mL,
P = 0.09). There were significant differences in the levels
of total IgE between infected and non-infected children
within the treatment groups (infection/no treatment vs.
no infection/no treatment, P < 0.001; infection/treatment
vs. no infection/treatment, P < 0.001). Relatively few chil-
dren (16%) had IgE levels below the upper range of nor-
mal for children living in industrialized countries [22]
(age 7 years [<248 IU/mL], 18.9%; age 8 years [<280 IU/
mL], 16.5%; age 9 years [<304 IU/mL], 17.3%; age 10
years [<328 IU/mL], 24.7%; age ≥11 years [<114 IU/mL],
Table 1: Baseline characteristics of the four study groups.
Variable Infection/No treatment 
(n = 100)
No infection/No treatment 
(n = 100)
Infection/treatment 
(n = 100)
No infection/Treatment 
(n = 100)
Age (years)
Mean (SD) 9.5 (2.0) 9.3 (1.8) 9.2 (1.6) 9.4 (1.8)
Sex
Male/Female 55/45 47/43 50/50 54/46
Socioeconomic level
Mean (SD) 2.6 (1.1) 2.0 (0.9) 2.2 (0.9) 1.9 (0/8)
Body mass index (kg/m2)
Mean (SD) 15.8 (1.8) 15.9 (2.5) 15.6 (1.5) 16.1 (2.4)
Crowding (persons/room)
Mean (SD) 2.7 (1.2) 2.4 (1.2) 2.8 (1.1) 2.4 (1.1)
Geohelminth prevalence 
(%)
Any 100 0 100 0
A. lumbricoides 75 0 73 0
T. trichiura 76 0 80 0
Hookworm 19 0 15 0
S. stercoralis 3 0 3 0
Intensity, GM (range) epg
A. lumbricoides 5,658 (70–227,500) 0 6,512 (70–182,700) 0
T. trichiura 602 (70–40,250) 0 583 (70–13,720) 0
Number of albendazole 
treatments
0 98% 97% 0% 0%
1–3 2% 2% 4% 0%
4–6 0% 0% 3% 8%
7 0% 1% 93% 92%
GM – geometric mean. SD – standard deviation. Epg – eggs per gramme of stool. Anthelmintic treatments were with single doses of 400 mg of 
albendazole.Page 4 of 11
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ment group was associated with levels of total IgE at base-
line in any of the 4 models (Table 2). Parameters of
geohelminth infection were strongly positively associated
with fold-increased levels (OR>1) of total IgE in all mod-
els: a) any geohelminth parasite (Model 1, P < 0.001;
Model 4, P = 0.001); b) infections with T. trichiura (Model
2, P < 0.001); c) increasing infection intensities with T.
trichiura (Model 3, test for trend across tertiles, P < 0.001);
and d) increasing levels of anti-A. lumbricoides IgG anti-
bodies (Model 4, test for trend across tertiles, P < 0.001).
Factors associated with changes in total IgE
Geometric mean levels of total IgE at 12 months and geo-
metric mean percent changes in IgE levels (brackets) in
the 4 study groups were: infection/no treatment, 1,045
IU/mL (79.5% or a posttreatment fall (-) of 20.5% com-
pared to pretreatment levels); no infection/no treatment,
833 IU/mL (101.0% or +1.0%); infection/treatment, 999
IU/mL (63.8% or -36.2%); and no infection/treatment,
395 IU/mL (66.0% or -34.0%). Overall in the treatment
and no treatment groups, IgE levels fell significantly by (-
)35.1% (P < 0.0001) and (-)10.4% (P = 0.0004), respec-
tively. Significantly greater declines in IgE levels were
observed in the treatment groups compared to the no
treatment groups for both non-infected (P < 0.001) and
infected (P = 0.0003) children (Figure 2A). Anthelmintic
treatment had relatively little impact on the proportion of
children with levels of IgE within the normal range for
children in industrialized countries [22]: (age 7 years
[<248 IU/mL), 17.6%; age 8 years [<280 IU/mL], 21.5%;
age 9 years [<304 IU/mL], 17.3%; age 10 years [<328 IU/
mL], 33.8%; age ≥11 years [<114 IU/mL], 12.6%). The
factors associated with changes in IgE levels are shown in
Table 3. Receipt of albendazole treatment was strongly
associated with falls (OR<1) in total IgE over the 12-
month period in all models (Table 3). The following var-
iables were also significantly associated with falls in IgE:
a) infection with any geohelminth at baseline (Model 1, P
= 0.01); b) increasing infection intensities with A. lumbri-
coides at baseline (Model 3, test for trend across tertiles, P
= 0.05) and c) increasing levels of anti-A. lumbricoides IgG
at baseline (Model 4, test for trend across tertiles, P =
0.02). Increases in IgE over the study period (OR>1) were
associated with the presence of any geohelminth infection
at 12 months (Models 1 and 4, P = 0.02), and increasing
levels of anti-A. lumbricoides IgG at 12 months (Model 4,
test for trend across tertiles, P = 0.03).
Prevalence of infection with geohelminths during the studyFigur  1
Prevalence of infection with geohelminths during the study. Shown is the prevalence of infections before receiving the 1st dose 
of albendazole (0 months) and at 12 months (before receiving the 7th dose of albendazole) in the four study groups. Groups 
are: 1) infection/no treatment (light grey columns), 2) no infection/no treatment (dark grey), 3) infection/treatment (hatched), 
and 4) no infection/treatment (checked).
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All children (100%) had positive serologic assays for anti-
A. lumbricoides IgG before and after treatment. Per cent
changes in levels of specific IgG in the 4 study groups (Fig-
ures 2B) were: infection/no treatment, 90.2% (-9.8%); no
infection/no treatment 108.9% (+8.9%); infection/treat-
ment, 74.4% (-25.6%); and no infection/treatment,
80.3% (-19.7%). Significantly greater reductions in levels
of specific IgG antibodies were observed in treatment
Table 2: Relationship between baseline variables and levels of total IgE before treatment.
Geometric mean total IgE at baseline
Variable Model 1 Model 2 Model 3 Model 4
Fold difference 
(95% CI)
p value Fold difference 
(95% CI)
p value Fold difference 
(95% CI)
p value Fold difference 
(95% CI)
p value
Age (per year) 1.01 
(0.94–1.10)
0.74 1.01 
(0.94–1.09)
0.78 1.02 
(0.94–1.10)
0.70 1.05 
(0.97–1.12)
0.23
Sex (females 
relative to males)
0.83 
(0.64–1.07)
0.15 0.84 
(0.65–1.09)
0.20 0.85 
(0.66–1.10)
0.22 0.86 
(0.68–1.10)
0.24
Body Mass Index 
(per kg/m2)
1.01 
(0.94–1.08)
0.81 1.01 
(0.95–1.08)
0.73 1.01 
(0.95–1.08)
0.68 1.00 
(0.94–1.06)
0.98
Socioeconomic 
level (per unit 
score)
1.10 
(0.95–1.27)
0.18 1.09 
(0.94–1.26)
0.25 1.11 
(0.96–1.28)
0.17 1.06 
(0.93–1.21)
0.40
Crowding (per 
person/sleeping 
room)
0.98 
(0.87–1.10)
0.74 0.98 
(0.87–1.10)
0.74 0.97 
(0.87–1.09)
0.66 1.00 
(0.90–1.11)
0.99
Treated group 
(relative to 
untreated)
0.95 
(0.73–1.24)
0.71 0.95 
(0.73–1.23)
0.69 0.96 
(0.74–1.25)
0.79 0.96 
(0.75–1.23)
0.75
Geohelminth 
prevalence at t = 0 
(present versus 
absent)
Any 2.10 
(1.60–2.75)
<0.001 1.55 
(1.19–2.01)
0.001
A. lumbricoides 1.38 
(0.99–1.91)
0.06
T. trichiura 1.79 
(1.31–2.46)
<0.001
Hookworm 1.60 
(0.99–2.60)
0.06 1.55 
(0.95–2.52)
0.08
S. stercoralis 0.77 
(0.26–2.23)
0.62 0.71 
(0.24–2.05)
0.52
Geohelminth 
intensity (epg) at t 
= 0 (relative to no 
infection)
A. lumbricoidesa 1–8000 1.55 
(1.05–2.30)
0.03
>8000 1.33 
(0.85–2.08)
0.21
T. trichiurab 1–500 1.32 
(0.90–1.96)
0.16
>500 2.23 
(1.44–3.43)
<0.001
Anti-A. lumbricoides 
antibodies at t = 0
(relative to lower 
tertile) IgGc
middle tertile 1.64 
(1.21–2.23)
0.001
upper tertile 3.51 
(2.55–4.82)
<0.001
Statistical significance, after Bonferroni corrections, is inferred by: Model 1 (P < 0.05), Model 2 (P < 0.01), Model 3 (P < 0.008), and Model 4 (P < 
0.02). Statistically significant P values are shown in bold for each model. P values for trend: a0.08, b, c<0.001.Page 6 of 11
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Table 3: Relationship between variables and geometric mean fold change in total IgE at 12 months compared to baseline.
Explanatory variable Fold difference in geometric mean of fold change in   total IgE from 0 to 12 months
Model 1 Model 2 Model 3 Model 4
Fold 
difference 
(95% CI)
p value Fold 
difference 
(95% CI)
p value Fold 
difference 
(95% CI)
p value Fold 
difference 
(95% CI)
p value
Age (per year) 1.01 
(0.94–1.10)
0.08 0.98 
(0.95–1.00)
0.10 0.98 
(0.95–1.00)
0.08 0.98 
(0.95–1.00)
0.09
Sex (females relative to 
males)
0.97 
(0.88–1.06)
0.48 0.96 
(0.88–1.06)
0.42 0.96 
(0.88–1.06)
0.44 0.97 
(0.88–1.06)
0.50
Body Mass Index (per 
kg/m2)
1.00 
(0.98–1.02)
0.89 1.00 
(0.98–1.02)
0.95 1.00 
(0.98–1.02)
0.98 1.00 
(0.98–1.02)
0.89
Socioeconomic level 
(per unit score)
0.97 
(0.92–1.02)
0.22 0.97 
(0.92–1.02)
0.22 0.97 
(0.92–1.02)
0.19 0.97 
(0.93–1.02)
0.30
Crowding (per person/
sleeping room)
0.98 
(0.94–1.02)
0.28 0.98 
(0.94–1.02)
0.31 0.98 
(0.94–1.02)
0.31 0.98 
(0.94–1.02)
0.26
Treated group (relative 
to untreated)
0.76 
(0.69–0.84)
<0.001 0.75 
(0.68–0.84)
<0.001 0.75 
(0.68–0.84)
<0.001 0.77 
(0.70–0.86)
<0.001
Geohelminth 
prevalence at t = 0 
(present versus absent).
Any 0.88 
(0.80–0.97)
0.01 0.89 
(0.81–0.99)
0.03
A. lumbricoides 0.95 
(0.85–1.07)
0.38
T. trichiura 0.95 
(0.84 1.07)
0.40
Hookworm 0.81 
(0.67–0.96)
0.02 0.80 
(0.67–0.96)
0.02
S. stercoralis 1.15 
(0.78–1.69)
0.47 1.19 
(0.81–1.75)
0.38
Geohelminth 
prevalence at t = 12 
(present versus absent).
Any 1.14 
(1.02–1.26)
0.02 1.13 
(1.02–1.26)
0.02
A. lumbricoides 1.11 
(0.98–1.26)
0.11
T. trichiura 1.04 
(0.92–1.18)
0.49
Hookworm 1.04 
(0.81–1.33)
0.76 1.08 
(0.84–1.38)
0.56
S. stercoralis 0.92 
(0.56–1.51)
0.74 0.92 
(0.56–1.52)
0.76
Geohelminth intensity 
(epg) at t = 0 (relative 
to no infection)
A. lumbricoidesa 1–8000 0.94 
(0.82–1.08)
0.40
>8000 0.86 
(0.73–1.00)
0.05
T. trichiurab 1–500 1.06 
(0.92–1.21)
0.45
>500 0.93 
(0.79–1.10)
0.42
Geohelminth intensity 
(epg) at t = 12 (relative 
to no infection)
A. lumbricoidesc 1–8000 1.12 
(0.94–1.35)
0.20
>8000 1.15 
(0.93–1.42)
0.21
T. trichiurad 1–500 1.08 
(0.93–1.25)
0.32
>500 1.03 
(0.85–1.25)
0.76
Anti-A. Lumbri-coides 
IgG t = 0e
middle tertile 0.87 
(0.75–1.00)
0.05
upper tertile 0.81 
(0.68–0.96)
0.02
Anti-A. lumbricoides IgG 
t = 12f
middle tertileg 1.14 
(0.99–1.31)
0.06
upper tertile 1.22 
(1.02–1.46)
0.03
Statistical significance, after Bonferroni corrections, is inferred by: Model 1 (P < 0.03), Model 2 (P < 0.006), Model 3 (P < 0.004), and Model 4 (P < 0.008). 
Statistically significant P values are shown in bold for each of the 4 models. P values for test for trend: a0.05 b0.61 c0.13 d0.55 e0.018 f0.025. gTertile 
boundaries are defined by the t = 0 data and applied also to the t = 12 data.
BMC Immunology 2008, 9:33 http://www.biomedcentral.com/1471-2172/9/33compared to no treatment groups (IgG, P≥0.001 for both
infected and non-infected children).
Infections with A. lumbricoides and T. trichiura, but not
hookworm or S. stercoralis, were positively associated with
anti-A. lumbricoides IgG at baseline. The A. lumbricoides
infection intensity stratum of 1–8,000 epg was associated
with increased baseline antibody levels compared to the
egg-negative group (1.5-fold increase, 95% CI 1.22–1.85,
P < 0.001), and a similar but non-significant trend was
observed for the A. lumbricoides infection stratum of
>8,000 epg. Increased baseline antibodies were strongly
associated with the heavy infection stratum (>500 epg) of
T. trichiura infection, (1.55, 95% CI 1.23–1.95, P <
0.001). Tests for trend across strata of infection intensities
for A. lumbricoides and T. trichiura were not statistically sig-
nificant. Percent change in levels of anti-A. lumbricoides
IgG antibodies was negatively associated with A. lumbri-
coides infection at baseline, but not at 12 months, and was
not associated with the other geohelminth parasites. Anti-
body levels fell by a factor of 0.81 (95% CI 0.69–0.93, P =
0.004) in the >8,000 epg stratum of A. lumbricoides infec-
tion compared to egg-negative individuals.
Effect of albendazole treatment on changes in levels of total IgE (A) and Ascaris lumbricoides-specific IgG (B) antibodies at 12 mon hs compared to baselineFigure 2
Effect of albendazole treatment on changes in levels of total IgE (A) and Ascaris lumbricoides-specific IgG (B) antibodies at 12 
months compared to baseline. 100% indicates no change. Groups are: 1) infection/no treatment (light grey boxes), 2) no infec-
tion/no treatment (dark grey), 3) infection/treatment (hatched), and 4) no infection/treatment (checked). Box plots show 
median (middle line), interquartile range (box margins), 95% data range (bars), and outlying values (circles). Statistical signifi-
cance in both Figures, after Bonferroni corrections (only the 4 comparisons shown were considered), is inferred by P < 0.0125.
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The factors that determine levels of polyclonal IgE in pop-
ulations living in the rural tropics are poorly understood
but the presence of geohelminth infections and host
genetic factors are likely to be important [10,11]. In this
study, we have investigated the association between geo-
helminth infections and total IgE within the context of
other known determinants of IgE (e.g. age, and nutritional
and socioeconomic status) in a population of school chil-
dren living in rural tropical communities in Ecuador
where geohelminth infections are highly endemic [1,19]
and have assessed the impact of repeated treatments with
albendazole over the period of 12 months on IgE levels.
Levels of IgE at baseline were strongly positively associ-
ated with geohelminth infection and anti-A. lumbricoides
IgG antibodies. Because of extensive immunologic cross-
reactivity between antigens from different geohelminth
parasites [21], levels of anti-A. lumbricoides IgG antibodies
are likely to reflect past and current infections with geo-
helminth infections in general – levels of anti-A. lumbri-
coides antibodies at baseline were strongly associated with
infections with A. lumbricoides and T. trichiura. Over the
12-month observation period during which two of the
study groups received repeated anthelmintic treatments,
fold falls in IgE levels were strongly independently associ-
ated with the receipt of anthelmintic treatment, any geo-
helminth infection at baseline, increasing infection
intensities with A. lumbricoides, and increasing levels of
anti-A. lumbricoides IgG antibodies. In contrast, fold
increases in IgE levels over the observation period were
associated with the presence of any geohelminth infection
at 12 months and increasing levels of anti-A. lumbricoides
IgG at 12 months. These findings suggest that geo-
helminth infections are important determinants of poly-
clonal IgE levels and that anthelmintic treatments are
capable of significantly reducing levels of IgE over a
period of 12 months but that, independent of treatment,
active infections and chronic and continued exposures
(indicated by post-treatment levels of anti-A. lumbricoides
IgG) are important determinants of elevated IgE levels
post-treatment.
To our knowledge, previous studies have not examined
specifically the association between total IgE and intesti-
nal helminth infections in endemic populations and the
effects of anthelmintic treatment on IgE levels in the con-
text of other important risk factors. The study sample was
derived from an intervention study that examined the
effects of repeated anthelmintic treatments on atopy and
clinical allergy over a period of 12 months [19]. Random
samples of children were selected from children complet-
ing follow-up into four groups defined by geohelminth
infection status and treatment allocation. The random
samples of children were not selected within schools, the
original unit of randomization, because of the small sizes
of schools. If there were appreciable differences between
schools then this would increase the likelihood of imbal-
ance between the samples. However, this does not seem to
have occurred, because the four groups were comparable
with respect to the a priori confounders (i.e. age, sex, and
crowding) and these characteristics were similar to that
observed in the original pre-treatment study population
[19] that recruited a high proportion of all children
attending 68 rural schools. Socioeconomic level was
lower in the infected groups compared to non-infected
groups – this may not be surprising given the known asso-
ciations between these infections and poverty [5,13,16].
Another important strength of the study is the collection
of data on potential confounding factors and controlling
for these in the analysis. Residual confounding by socioe-
conomic level cannot be excluded because this variable
was controlled for in the analysis using a score that is
unlikely to capture the complexity of social and economic
disparities within a population. However, residual con-
founding would seem unlikely because there was no indi-
cation of an association between socioeconomic score
and the IgE parameters in the multivariable models. Our
findings are likely to be relevant to schoolchildren living
in areas of the rural tropics where geohelminth infections
are highly endemic.
Investigations of IgE in helminth-exposed populations or
infected patient groups have examined the effects on IgE
levels of anthelmintic treatment [16-18] and the effects of
migration on IgE levels in individuals that migrate from
endemic to non-endemic countries. Studies of the effects
of anthelmintic treatment on IgE levels have shown that
levels of IgE remain highly elevated 2 to 3 years after pro-
viding effective anthelmintic treatment [16,17]. A study of
34 expatriates with filarial helminth infections and pro-
vided effective anthelmintic treatment showed that the
mean IgE level fell to within normal limits after a median
of 33 months [18]. Studies of migrants from helminth-
endemic countries to non-endemic countries have shown
that IgE levels take at least 10 years to decline to those
observed in the native populations [23,24]. In the current
study, we observed declines in total IgE of 34.0% and
36.2% in the non-infected and infected treatment groups,
respectively, and geometric mean levels of IgE remained
highly elevated at 12 months after treatment. A fall was
observed in the infected non-treatment group (of 20.5%)
that may be explained by treatment contamination. IgE
levels did not change in the non-infected non-treatment.
There are likely to be differences between different study
populations that depend on the effectiveness of
anthelmintic treatment for the parasites studied and
whether individuals remain exposed to helminth infec-
tions (i.e. by continued residence in an endemic area).
Together these studies show that IgE levels may remainPage 9 of 11
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though the life of IgE in the circulation is approximately 3
to 4 days, and indicate that helminth infections have long-
lasting effects on host immunity.
Possible explanations for the longevity of the IgE response
include. 1) The continued exposure to infectious parasite
stages in the environment or non-curative chemotherapy.
In the current study all children had significant levels of
anti-A. lumbricoides IgG both pre- and post-treatment that
may indicate intense and continued transmission of geo-
helminth infections over the course of the study. ; 2) The
immune system may be programmed for Th2 responses in
early life through exposure to maternal helminth infec-
tions, early childhood infections [25], or other Th2-skew-
ing environmental exposures and the effect may be long-
lasting. For example, newborns of Ethiopian immigrant
mothers with high level of IgE are born with relatively
high levels of IgE in cord blood that are proportionate to
maternal values [26]. 3) Certain populations may main-
tain high levels of IgE because of genetic predisposition.
Levels of IgE reflect a complex interaction between genetic
factors and environmental exposures. In the United
States, ethnicity appears to be the most important deter-
minant of IgE levels although this is likely to reflect a
number of genetic and environmental effects [9]. A study
among a genetically isolated population in Nepal where
A. lumbricoides and hookworm infections were highly
endemic provided evidence that more than 50% in varia-
bility in total IgE levels was attributable to genetic factors
[11]. Studies of highly parasitized Aboriginal Australians
have provided evidence that a polymorphism in the high-
affinity IgE receptor and HLA-DR genes explained 12.4%
[10] and 33% [27], respectively, of the variation in serum
total IgE. Unfortunately, we were not able to investigate
the role of genetic factors in this study. However, the fact
that total IgE levels are elevated in almost all individuals
infected with geohelminth parasites [12] indicates that
geohelminth infections are potent environmental deter-
minants of IgE.
Conclusion
Our data provide strong evidence for geohelminth infec-
tions being an important determinant of the highly ele-
vated levels of IgE observed in a population of school
children living in an area of the rural tropics endemic for
these parasites. Parameters of geohelminth infection were
strongly associated with pretreatment IgE levels and also
with the magnitude of the decline in IgE after
anthelmintic treatment. Repeated anthelmintic treat-
ments resulted in significant reductions in levels of total
IgE of 34.0 to 36.2%. However, the failure to reduce levels
of total IgE to 'normal' values in a high proportion of chil-
dren may be explained by a combination of factors that
may include continued exposure to parasites in a contam-
inated environment, programming for a Th2-skew in early
life and long-lasting immunologic effects induced by
helminth parasites, and other unidentified environmental
and genetic factors.
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